View as cardsView as table101 Projects
Fiscal Year Awarded
Funding amount
Principal Investigator
A degrader approach to mechanism-based therapeutics in pulmonary arterial hypertension

2026

Adrian Salic

Advancing the development of HUWE1 inhibitors for cancer treatment

2026

Ying Lu

Bacterial siderophores for accelerated mineral weathering and carbon sequestration in seawater

2026

Pamela Silver

Brain specific modulation of thyroid hormone levels

2026

Bernardo Sabatini

Development of a novel therapeutic to accelerate epithelial repair following viral respiratory infection

2026

Ruth Franklin

Development of targeted ectodomain shedding molecules

2026

Stephen Blacklow

Enhanced dual-AAV gene delivery to treat hereditary deafness

2026

David Corey

Enhancing regulatory T cell function for adoptive CAR Treg therapy to treat autoimmune disease

2026

Arlene Sharpe

Melanocortin 1 receptor agonists for preventing skin cancer

2026

Andrew Kruse

Non-invasive theranostics for endometriosis

2026

Ulrich von Andrian

Potassium channel enhancers to treat pain and epilepsy

2026

Bruce Bean

Potassium channel inhibitors for symptomatic treatment of multiple sclerosis

2026

Bruce Bean

Precision modulation of IL-10 pathways via IL-10 receptor-targeted nanobodies

2026

Jun Huh

Purification pipeline

2026

Michael Springer

Relaxin family peptide receptor 2 modulators as therapeutics

2026

Andrew Kruse

Targeting a protein to promote remyelination

2026

Lee Rubin

Targeting Ecdysone signaling for control of disease vector and other insects

2026

Norbert Perrimon

Targeting novel negative regulators to improve CAR T cell therapy responses in solid tumors

2026

Arlene Sharpe

Targeting tau hyperphosphorylation to develop novel therapeutics for Alzheimer’s Disease and other tauopathies

2026

John Flanagan

Therapeutic development of secreted peptides uncovered by Barcoded Ligand Sequencing

2026

Michael Greenberg